CBD Life Sciences Inc (CBDL): News – Looks Good https://www.otcmarket...

RickRat · 2025-02-21T16:08:30.6100000Z

News – Looks Good https://www.otcmarkets.com/stock/CBDL/news/CBDL-Launches-New-Mushroom-Supplement-Drink--Smoothie-Bar?id=468080

Play Episode

4min

Proactive - Interviews for investors

AXP Energy expands financial mining operations with BitFuFu partnership

AXP Energy Managing Director Dan Lanskey joined Steve Darling from Proactive to announce the successful completion of the company’s initial gas-to-power trial at the Pathfinder production hub in Colorado. Over a 14-day period, AXP delivered 1.5 MW/hour of electricity with 85% uptime, supporting efficient bitcoin mining operations. Following system optimizations, uptime has now exceeded 90%, marking a significant milestone for the project. AXP has secured the backing of NASDAQ-listed BitFuFu, Inc., through its joint venture partner, to advance the next phase of bitcoin mining expansion at the Pathfinder Field. The site, which has a steady supply of natural gas from AXP’s 24 wells, holds further production potential to support large-scale mining operations. Looking ahead, AXP is targeting the phased delivery of 25 MW of electricity by the end of 2025. The next immediate step is expanding the first site to 5 MW, with BitFuFu supplying additional ASIC miners and equipment. Beyond the Pathfinder Field, AXP and BitFuFu are also exploring additional opportunities across North America, with AXP serving as the primary energy provider for future mining projects. #proactiveinvestors #axpenergylimited #asx #axp #otc #aunxf #BitcoinMining #OilAndGas #CryptoEnergy #BitFuFu #StrandedGas #EnergyInnovation #OffGridPower #CryptoMining #RenewableEnergy #Nasdaq #EnergyMarkets #Investment #OilProduction

Proactive - Interviews for investors

Foresight Solar Fund fund manager discusses strong returns despite market challenges

Foresight Solar Fund Ltd fund manager Ross Driver takes Proactive's Stephen Gunnion through the company's full-year results and its strong portfolio performance despite record-low irradiation levels in the UK. Driver highlighted that Foresight Solar generated over 1,000 gigawatt hours of renewable energy—enough to power approximately 370,000 UK homes. He also discussed the company’s stable dividend policy, with an 8p per share dividend for 2024 and a planned increase to 8.1p per share in 2025. Foresight Solar’s active hedging strategy and capital allocation approach have supported steady shareholder returns, with £67 million returned to investors through dividends and buybacks. Driver reaffirmed the company’s focus on capital efficiency, debt reduction, and strategic growth through its proprietary development pipeline. The company recently doubled its Spanish development pipeline to 400MW of battery storage, which he described as a key step in future value creation. Regarding market challenges, Driver acknowledged high interest rates and sector outflows but emphasised the long-term strength of renewables, supported by government policies in the UK and Europe. "We remain confident in the portfolio's quality and our income and growth strategy to drive total shareholder returns," he stated. For more updates on Foresight Solar Fund Ltd, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future updates. #ForesightSolar #RenewableEnergy #SolarInvestment #DividendGrowth #CleanEnergy #SustainableInvesting #BatteryStorage #InvestorUpdates #EnergyTransition

Proactive - Interviews for investors

Sona Nanotech CMO discusses THT's potential to enhance immunotherapy efficacy

Sona Nanotech Inc chief medical officer Dr Carman Giacomantonio takes Proactive's Stephen Gunnion through the company’s latest findings related to its targeted hyperthermia therapy (THT), which he described as showing “very enabling immunogenic” effects in recent experiments. The THT platform works by delivering controlled heat to the core of a tumour, triggering a natural cell death response and activating the body's immune system. Giacomantonio explained that this process exposes tumour proteins to immune cells, increasing the chance that they will be recognised and attacked. He noted that “all cancer cells have this kind of evolutionary quality” of resisting cell death, but THT stresses the cells enough to induce it. These latest experiments build on data first shared in December, with increased sample sizes confirming the reproducibility of the results. According to Giacomantonio, tumours treated with saline or checkpoint inhibitors alone continued to grow, while those exposed to THT and the immune modulator PD1 showed complete inhibition or reduction in growth. Looking ahead, he said the company plans to expand testing to demonstrate systemic immune responses, with the goal of treating metastatic cancers by targeting a single tumour site. Visit Proactive's YouTube channel for more company updates. Don’t forget to give this video a like, subscribe to the channel, and enable notifications so you never miss future content. #SonaNanotech #CancerTherapy #TargetedHyperthermia #Immunotherapy #BiotechNews #TumourTreatment #CancerResearch #MedicalInnovation #PD1Inhibitor #MetastaticCancer #HealthcareTech #OncologyBreakthrough

Proactive - Interviews for investors

Crucial Innovations CEO JP Doran on unique proposition and growth strategy

Crucial Innovations Corp CEO Jon-Paul Doran talked with Proactive's Stephen Gunnion about the company’s expansion. The US-based firm, soon to be quoted on the OTC markets, operates a vertically integrated business with cultivation facilities in South Africa and a dispensary in the UK. Doran highlighted the company’s seed-to-sale model, which ensures control over quality and supply. He explained that their proprietary genetics provide an edge in the medicinal market, enabling precision medicine for patients. With a low-cost production base in South Africa and a growing European and UK market focus, the company is positioned for long-term growth. Discussing the decision to list in the US, Doran cited higher investor interest and market potential compared to the UK. He expects Crucial Innovations to start trading on the OTCQB by mid-to-late April, with a plan to uplist to the OTCQX and eventually Nasdaq. The company also has an aggressive acquisition strategy, aiming to acquire high-efficiency operators to boost its net asset value, revenue, and human capital. “We want to be a driver of consistent quality,” Doran emphasized, highlighting South Africa’s progressive stance and the expertise of its cultivation specialists. Watch the full interview to learn more about Crucial Innovations’ vision and upcoming milestones. Don't forget to like, subscribe, and turn on notifications for more updates from Proactive! #CrucialInnovations #OTCMarkets #Investing #CannabisIndustry #JPdoran #SouthAfrica #SeedToSale #OTCQB #OTCQX #Nasdaq #ProactiveInvestors

Followers	29
Posts	1750
Boards Moderated	0
Alias Born	02/03/2015

Volume:	3,023,448
Day Range:	0.0003 - 0.0005
Bid:	0.0003
Ask:	0.0005
Last Trade Time:	3:42:03 PM EDT
Total Trades:	21

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

CBDL Detailed Quote

Recent CBDL News

More CBDL News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent CBDL News

Go Ad-Free